Analysis

$2162 analysis on 6ix - valuation, growth, dividend & more for Keymed Biosciences, Inc.

Track Keymed Biosciences, Inc. (2162) on 6ix - releases, events, and the audience already following the stock.

website$2162/analysis/2162

Keymed Biosciences, Inc.

Run a Simply Wall St-style analysis on $2162 (Keymed Biosciences, Inc.) - valuation, growth, past performance, dividend, ownership, and community notes on 6ix.

View the company page